Ginkgo Bioworks announced today that Co-Founder and CEO Jason Kelly is scheduled to participate in a presentation at the 40th Annual J.P. Morgan Healthcare Conference on January 12, 2022 at 3:45 p.m. Eastern Time.
| BOSTON, Jan. 5, 2022 /PRNewswire/ --Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, announced today that Co-Founder and CEO Jason Kelly is scheduled to participate in a presentation at the 40th Annual J.P. Morgan Healthcare Conference on January 12, 2022 at 3:45 p.m. Eastern Time.
Further details, a webcast link, and a replay of the presentation will be posted on the company’s investor relations website at https://investors.ginkgobioworks.com/events. About Ginkgo Bioworks Ginkgo is building a platform to enable customers to program cells as easily as we can program computers. The company’s platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo has also actively supported a number of COVID-19 response efforts, including K-12 pooled testing, vaccine manufacturing optimization, and therapeutics discovery. For more information, visit www.ginkgobioworks.com. Ginkgo Bioworks Contacts: INVESTOR CONTACT: MEDIA CONTACT:
SOURCE Ginkgo Bioworks | ||
Company Codes: NYSE:DNA |
View original content to download multimedia:
